Citadel Advisors’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-633,162
| Closed | -$11.9M | – | 5444 |
|
|
2019
Q3 | $11.9M | Sell |
633,162
-2,447,325
| -79% | -$46.2M | 0.01% | 1077 |
|
|
2019
Q2 | $36.3M | Sell |
3,080,487
-16,410
| -0.5% | -$193K | 0.02% | 518 |
|
|
2019
Q1 | $42.3M | Buy |
3,096,897
+665,922
| +27% | +$9.09M | 0.02% | 444 |
|
|
2018
Q4 | $24.9M | Buy |
2,430,975
+33,853
| +1% | +$347K | 0.01% | 584 |
|
|
2018
Q3 | $39.9M | Buy |
2,397,122
+629,337
| +36% | +$10.5M | 0.02% | 477 |
|
|
2018
Q2 | $27.9M | Buy |
1,767,785
+1,492,496
| +542% | +$23.6M | 0.01% | 581 |
|
|
2018
Q1 | $3.5M | Sell |
275,289
-2,109,652
| -88% | -$26.8M | ﹤0.01% | 1533 |
|
|
2017
Q4 | $27.3M | Buy |
2,384,941
+551,387
| +30% | +$6.31M | 0.02% | 568 |
|
|
2017
Q3 | $22.5M | Buy |
1,833,554
+1,127,266
| +160% | +$13.8M | 0.02% | 608 |
|
|
2017
Q2 | $8.09M | Buy |
706,288
+238,901
| +51% | +$2.74M | 0.01% | 955 |
|
|
2017
Q1 | $9.72M | Buy |
467,387
+431,691
| +1,209% | +$8.98M | 0.01% | 898 |
|
|
2016
Q4 | $742K | Sell |
35,696
-800,428
| -96% | -$16.6M | ﹤0.01% | 2189 |
|
|
2016
Q3 | $27.4M | Buy |
836,124
+754,353
| +923% | +$24.7M | 0.03% | 405 |
|
|
2016
Q2 | $2.04M | Sell |
81,771
-276,605
| -77% | -$6.91M | ﹤0.01% | 1449 |
|
|
2016
Q1 | $8.78M | Buy |
358,376
+30,489
| +9% | +$747K | 0.01% | 766 |
|
|
2015
Q4 | $10.8M | Sell |
327,887
-166,408
| -34% | -$5.5M | 0.01% | 818 |
|
|
2015
Q3 | $16.2M | Sell |
494,295
-78,257
| -14% | -$2.56M | 0.02% | 714 |
|
|
2015
Q2 | $30.3M | Sell |
572,552
-181,912
| -24% | -$9.64M | 0.03% | 541 |
|
|
2015
Q1 | $21.8M | Buy |
754,464
+335,211
| +80% | +$9.67M | 0.02% | 669 |
|
|
2014
Q4 | $12.2M | Buy |
419,253
+400,943
| +2,190% | +$11.7M | 0.01% | 842 |
|
|
2014
Q3 | $233K | Buy |
+18,310
| New | +$233K | ﹤0.01% | 2829 |
|